Patents Issued in November 7, 2017
-
Patent number: 9808612Abstract: In an embodiment, a connector or connector assembly for attaching a nasal cannula with a gas delivery hose includes a sensor port for a sensor probe positioned near an end of a nasal cannula, which can allow the sensor probe to be placed closer to the patient's nostrils than previous connector parts allowed. The connector can be configured to advantageously allow the nasal cannula to rotate relative to the gas delivery hose, thereby allowing a patient or healthcare provider to untangle or otherwise straighten the hose or the cannula. The connector assembly can be configured to automatically align locking protrusions on a first component with locking recesses on a second component, where insertion of the second component within the first component causes the second component to rotate relative to the first component, thereby aligning the locking protrusions with associated locking recesses.Type: GrantFiled: August 10, 2012Date of Patent: November 7, 2017Assignee: Fisher & Paykel Healthcare LimitedInventors: Laurence Gulliver, Michael Paul Ronayne, Charles William Douglas Irving
-
Patent number: 9808613Abstract: An implantable lead for stimulating patient tissue includes a lead body. A jacket is disposed over at least a portion of a length of the lead body. The jacket has an outer surface and an opposing inner surface. At least a portion of the outer surface of the jacket forms at least a portion of an outer surface of the lead. At least a portion of the inner surface of the jacket is open to the lead body. The jacket defines apertures each extending completely through the jacket. Electrodes are disposed along a distal end of the lead body. Terminals are disposed along a proximal end of the lead body. Conductors electrically couple the electrodes to the terminals. Conductor insulation is disposed over each of the conductors. At least a portion of the conductor insulation is in fluid communication with the local environment external to the lead via the apertures.Type: GrantFiled: August 8, 2013Date of Patent: November 7, 2017Assignee: Boston Scientific Neuromodulation CorporationInventors: Matthew Lee McDonald, Michael X. Govea
-
Patent number: 9808614Abstract: An implantable curved shaping part for externally shaping an implantable electrode line or a catheter, wherein the shaping part has a continuous first lumen to allow a portion of the electrode line or of the catheter to pass through, wherein the shaping part has an extruded tube formed from two materials, each coextruded over a predetermined wall segment, having different shrinkage behavior or has a portion of an extruded spiral tube, wherein one of the coextruded materials or the material of the spiral tube has a high Shore hardness, in particular, of 60 Shore or more.Type: GrantFiled: March 23, 2016Date of Patent: November 7, 2017Assignee: BIOTRONIK SE & Co. KGInventors: Detmar Jadwizak, Carsten Fruendt, Dajana Kaiser, Gordon Hillebrand
-
Patent number: 9808615Abstract: Medical leads include a lumen body at an end of the lead, and the lumen body includes multiple filar lumens. The lumen body is joined to a lead body, and electrical connectors are longitudinally spaced along the lumen body. Filars within the filar lumens are directed through filar passageways within the lumen body to attach to the electrical connectors on the lumen body. The filar passageways may be aligned with the filar lumens, and slots within the electrical connectors may be aligned with the filar passageways to facilitate assembly. The lumen body may provide additional stiffness to the end of the lead where the lumen body is located to facilitate lead insertion into the medical device. The filar lumens of the lumen body may have a longitudinally straight configuration so that the portions of filars within the filar lumens are held in a longitudinally straight configuration.Type: GrantFiled: January 23, 2017Date of Patent: November 7, 2017Assignee: MEDTRONIC, INC.Inventors: Michael R. Klardie, Michael J. Kern, Brian T. Stolz, Marty D. Martens
-
Patent number: 9808616Abstract: The present disclosure provides a regenerative peripheral nerve interface (RPNI) for a subject comprising an insulating substrate, at least one metallic electrode deposited onto the insulating substrate forming a thin-film array; a portion of the at least one metallic electrode surface having a layer of a first conductive polymer and a layer of decellularized small intestinal submucosa (SIS) coating a portion of the electrode, wherein a second conductive polymer is electrochemically polymerized through the SIS to form the regenerative peripheral nerve interface. The present disclosure also provides that a layer of muscle tissue contacts the regenerative peripheral nerve interface.Type: GrantFiled: January 13, 2012Date of Patent: November 7, 2017Assignees: THE REGENTS OF THE UNIVERSITY OF MICHIGAN, UNIVERSITY OF DELAWAREInventors: Paul S. Cederna, Melanie G. Urbanchek, David C. Martin
-
Patent number: 9808617Abstract: An active implantable medical device is disclosed herein having a radio-opaque marker. The radio-opaque marker can be formed within an exterior wall of the device or within recesses on the outside of the exterior wall. The implantable medical device can be a leadless pacemaker. The shape of the radio-opaque marker can be designed to facilitate visualization and identification of the location, orientation, and rotation of the implanted medical device by conventional fluoroscopy. Methods of use are also disclosed.Type: GrantFiled: August 21, 2013Date of Patent: November 7, 2017Assignee: Pacesetter, Inc.Inventors: Alan Ostroff, Paul Paspa, Peter M. Jacobson, Wade A. Keller, Christopher Alan Hubbard
-
Patent number: 9808618Abstract: An implantable pacemaker has a first housing and a second housing tethered to the first housing by an elongated electrical conductor. The elongated electrical conductor has a proximal end coupled to the first housing and a distal end coupled to the second housing and includes a signal line configured to carry an electrical signal between the first housing and the second housing.Type: GrantFiled: April 23, 2015Date of Patent: November 7, 2017Assignee: Medtronic, Inc.Inventor: Wade M Demmer
-
Patent number: 9808619Abstract: Electrotherapy systems and methods for delivering an electrostimulation treatment program to a user while reducing the risk of inducing cardiac fibrillation. The systems and methods detect electrostimulation treatment program delivery characteristics, including a pulse intensity above a preset limit; a pulse duration above a preset limit; an inappropriately compensated pulse; a charge per pulse above a predetermined limit; a current improperly exiting from a stimulation channel; a current present outside of a pulse; an excitation pulse and a compensation pulse generated on different channels; an inter-pulse time less than a predetermined limit; and a time between an excitation and a compensation pulse greater than a predetermined limit. The limits are selected in relation to an objective of reducing the risk of inducing cardiac fibrillation.Type: GrantFiled: February 10, 2012Date of Patent: November 7, 2017Assignee: Encore Medical Asset CorporationInventors: Felix Buhlmann, Etienne Dunant, Steve Guex, David Truffer, Pierre-Yves Mueller
-
Patent number: 9808620Abstract: Apparatuses and methods are disclosed that may be used to treat one or more restless leg syndrome (RLS) symptoms of a patient. One example method may include generating first and second stimulation waveforms using a waveform generator; electrically stimulating at least a portion of a sacral region of the patient, based on the first and second stimulation waveforms, using a number of electrodes; damping or interfering with electrical signals transmitted from the patient's brain to the patient's legs via a femoral nerve of the patient using the electrical stimulation; and reducing the one or more symptoms of RLS based on damping or interfering with the electrical signals transmitted from the patient's brain.Type: GrantFiled: April 19, 2017Date of Patent: November 7, 2017Assignee: INVICTA MEDICAL, INC.Inventor: Steven Thomas Kent
-
Patent number: 9808621Abstract: A method and system for applying therapeutic stimulation to a patient stricken with paralysis or other condition. The inventive method includes the steps of: inserting an acupuncture needle against the spine of the patient and applying an electrical potential to the needle with a signal that mimics natural neural impulses in the body. The needle is located depending on the nature of the patient's condition. In the illustrative application, the needle is inserted against the ligamentum flavum of the patient's spine at L3. In the best mode, the patient's legs are moved during the application of the electrical potential. The inventive system is adapted to minimize a notch reaction and includes an electrode inserted into a tissue of the patient and a circuit for applying an electrical potential to the electrodes with a signal that mimics natural neural impulses in the body.Type: GrantFiled: August 5, 2015Date of Patent: November 7, 2017Inventor: Laura Kelly
-
Patent number: 9808622Abstract: The invention generally relates to systems and methods for stimulating cellular function in biological tissue. In certain embodiments, the invention provides a method for stimulating cellular function within tissue that involves providing a first type of energy to a region of tissue, in which the first type is provided in an amount that inhibits cellular function within the region of tissue, and providing a second type of energy to the region of tissue, in which the second type is provided in an amount that facilitates cellular function within the region of tissue, wherein the combined effect stimulates cellular function within the tissue.Type: GrantFiled: April 10, 2017Date of Patent: November 7, 2017Assignee: HIGHLAND INSTRUMENTSInventor: Timothy Andrew Wagner
-
Patent number: 9808623Abstract: The present disclosure relates to a hearing system. The hearing system comprises an implantable device configured to be implanted under the skin of a wearer and an external device configured to be positioned at an ear of the wearer. The external device comprises a transmit system configured to generate a wireless signal for being transmitted to the implantable device.Type: GrantFiled: September 30, 2015Date of Patent: November 7, 2017Assignee: OTICON MEDICAL A/SInventors: Søren Kamaric Riis, Shahrokh Tahniat
-
Patent number: 9808624Abstract: A signal processing arrangement is described for signal processing in a bilateral hearing implant system having left side and right side hearing implants. An interaural coherence analysis module analyzes system input signals to produce an interaural coherence signal output characterizing reverberation-related similarity of the input signals.Type: GrantFiled: December 5, 2016Date of Patent: November 7, 2017Assignee: MED-EL Elektromedizinische Geraete GmbHInventors: Dirk Meister, Peter Schleich
-
Patent number: 9808625Abstract: The present invention is an improved spatial fitting and training system for a visual prosthesis. The system of the present invention maps projected locations of percepts, where a person perceives a percept from a visual prosthesis to the intended location of the percepts. The projected location may vary over time. This test results can be used to correct a visual prosthesis or spatially map the visual prosthesis.Type: GrantFiled: May 2, 2016Date of Patent: November 7, 2017Assignee: Second Sight Medical Products, Inc.Inventors: Robert J. Greenberg, Michael Barry, Gislin Dagnelie
-
Patent number: 9808626Abstract: Systems and methods are provided for delivering neurostimulation therapies to patients for treating chronic heart failure. A neural fulcrum zone is identified and ongoing neurostimulation therapy is delivered within the neural fulcrum zone. The implanted stimulation device includes a physiological sensor for monitoring the patient's response to the neurostimulation therapy on an ambulatory basis over extended periods of time and a control system for adjusting stimulation parameters to maintain stimulation in the neural fulcrum zone based on detected changes in the physiological response to stimulation.Type: GrantFiled: September 16, 2016Date of Patent: November 7, 2017Assignees: Cyberonics, Inc., East Tennessee State UniversityInventors: Imad Libbus, Badri Amurthur, Bruce H. KenKnight, Jeffrey L. Ardell
-
Patent number: 9808627Abstract: Systems and methods for enhancing or affecting neural stimulation efficiency and/or efficacy are disclosed. In one embodiment, a system and/or method may apply electromagnetic stimulation to a patient's nervous system over a first time domain according to a first set of stimulation parameters, and over a second time domain according to a second set of stimulation parameters. The first and second time domains may be sequential, simultaneous, or nested. Stimulation parameters may vary in accordance with one or more types of duty cycle, amplitude, pulse repetition frequency, pulse width, spatiotemporal, and/or polarity variations. Stimulation may be applied at subthreshold, threshold, and/or suprathreshold levels in one or more periodic, aperiodic (e.g., chaotic), and/or pseudo-random manners. In some embodiments stimulation may comprise a burst pattern having an interburst frequency corresponding to an intrinsic brainwave frequency, and regular and/or varying intraburst stimulation parameters.Type: GrantFiled: November 16, 2015Date of Patent: November 7, 2017Assignee: ADVANCED NEUROMODULATION SYSTEMS, INC.Inventors: Bradford Evan Gliner, Allen Wyler, Brad Fowler, W. Douglas Sheffield, Richard Kuntz, Kent Leyde, Leif R. Sloan
-
Patent number: 9808628Abstract: In some examples, a leadless pacing device (hereinafter, “LPD”) is configured for implantation in a ventricle of a heart of a patient, and is configured to switch between an atrio-ventricular synchronous pacing mode and an asynchronous ventricular pacing mode in response to detection of one or more sensing events, which may be, for example, undersensing events. In some examples, an LPD is configured to switch from a sensing without pacing mode to an atrio-ventricular synchronous pacing mode in response to determining, for a threshold number of cardiac cycles, a ventricular depolarization was not detected within a ventricular event detection window that begins at an atrial activation event.Type: GrantFiled: November 14, 2016Date of Patent: November 7, 2017Assignee: Medtronic, Inc.Inventors: Todd J Sheldon, Wade M Demmer
-
Patent number: 9808629Abstract: A delivery system assembly includes an outer tube, an inner member, extending within a lumen of the outer tube, and a deflectable shaft, extending within the outer tube lumen and around the inner member; the tube and inner member are longitudinally moveable with respect to the shaft, and a distal end of the inner member is located distal to the shaft within the tube lumen. A medical device can be loaded into the tube lumen, along a distal-most portion of the tube, and contained between the inner member and a distal opening of the tube lumen. Deflecting the shaft orients the distal-most portion for navigation of the assembly, and, when the distal end of the inner member is engaged within the tube lumen, distal movement of the tube, with respect to the shaft, causes similar distal movement of the inner member and the loaded medical device toward an implant site.Type: GrantFiled: February 2, 2015Date of Patent: November 7, 2017Assignee: Medtronic, Inc.Inventors: H. Allan Steingisser, Don H. Tran, William A. Berthiaume, Brent L. Locsin
-
Patent number: 9808630Abstract: An external device transfers a key to an implantable medical device over a proximity communication and then establishes a first far field communication session with the implantable medical device where the key is used for the first communication session. This first communication session may occur before implantation while the implantable medical device is positioned outside of the sterile field so that using a proximity communication is easily achieved. Once the implantable medical device is passed into the sterile field for implantation, the external device may then establish a second far field communication session with the implantable medical device where the last key that was used for the first communication session is again used for the second communication session which avoids the need for another proximity communication to occur within the sterile field.Type: GrantFiled: April 23, 2015Date of Patent: November 7, 2017Assignee: MEDTRONIC, INC.Inventors: Warren W. Ball, Ajinkya M. Joglekar, Nathan A. Torgerson, Matthew L. Plante
-
Patent number: 9808631Abstract: Systems and methods for communicating between medical devices. In one example, an implantable medical device comprising may comprise one or more electrodes and a controller coupled to the electrodes. The controller may be configured to receive a first communication pulse at a first communication pulse time and a second communication pulse at a second communication pulse time via the one or more electrodes. The controller may further be configured to identify one of three or more symbols based at least in part on the time difference between the first communication pulse time and the second communication pulse time.Type: GrantFiled: July 29, 2015Date of Patent: November 7, 2017Assignee: Cardiac Pacemakers, Inc.Inventors: Keith R. Maile, Michael J. Kane, Paul Huelskamp, Lance E. Juffer, Jeffrey E. Stahmann
-
Patent number: 9808632Abstract: An implantable medical device comprises a communication module that comprises at least one of a receiver module and a transmitter module. The receiver module is configured to both receive from an antenna and demodulate an RF telemetry signal, and receive from a plurality of electrodes and demodulate a tissue conduction communication (TCC) signal. The transmitter module is configured to modulate and transmit both an RF telemetry signal via the antenna and a TCC signal via the plurality of electrodes. The RF telemetry signal and the TCC signal are both within a predetermined band for RF telemetry communication. In some examples, the IMD comprises a switching module configured to selectively couple one of the plurality of electrodes and the antenna to the receiver module or transmitter module.Type: GrantFiled: January 23, 2015Date of Patent: November 7, 2017Assignee: Medtronic, Inc.Inventors: James D. Reinke, James K. Carney, Can Cinbis, David J. Peichel, Joseph Ballis
-
Patent number: 9808633Abstract: A device includes a signal generator module, a processing module, and a housing. The signal generator module is configured to deliver pacing pulses to an atrium. The processing module is configured to detect a ventricular activation event and determine a length of an interval between the ventricular activation event and a previous atrial event that preceded the ventricular activation event. The processing module is further configured to schedule a time at which to deliver a pacing pulse to the atrium based on the length of the interval and control the signal generator module to deliver the pacing pulse at the scheduled time. The housing is configured for implantation within the atrium. The housing encloses the stimulation generator and the processing module.Type: GrantFiled: October 31, 2012Date of Patent: November 7, 2017Assignee: Medtronic, Inc.Inventors: Matthew D. Bonner, Saul E. Greenhut, Todd J. Sheldon, Wade M. Demmer
-
Patent number: 9808634Abstract: The disclosed invention varies the width of the energy pulses with constant frequency and constant amplitude to regulate the amount of energy transferred from an energy transmitting device placed outside a patient to an energy receiver inside the patient. The pulse width is achieved with a modulation technique, PWMT, to control the amount of energy transferred from the external energy transmitting coil in the system to the implanted receiver. The PWMT is used to digitally vary the amount of power from the power amplifier that drives the transmitting coil. Compared to previous analog systems a PWM system is a great deal more efficient and can easily be controlled from a digital domain system such as a microprocessor.Type: GrantFiled: November 27, 2013Date of Patent: November 7, 2017Inventor: Peter Forsell
-
Patent number: 9808635Abstract: A data collection device (100) is described which monitors the environmental conditions and the operations of a medical device (10). The data collection device may be arranged to communicate wirelessly via a cloud computing environment with a central computer (210). The central computer compares the reported use data with a preventive maintenance model to predict when or how the medical device will fail. In addition, the central computer may integrate reports from many data collection devices operating in various environments for the purpose of analyzing and improving the predictive maintenance model.Type: GrantFiled: August 23, 2013Date of Patent: November 7, 2017Assignee: Koninklijke Philips N.V.Inventor: George Paul Gumbrell
-
Patent number: 9808636Abstract: A defibrillating system includes a processor coupled to a memory. The processor and the memory are configured to identify a treatment event associated with treatment of a victim with the defibrillating system, and transmit a representation of a portion of an ECG signal associated with the identified treatment event. In some cases, the processor and the memory are configured to identify the portion of the ECG signal associated with the identified treatment event. In some cases, the portion of the ECG signal is of a predetermined length of time having a start time and an end time based on a time associated with the identified treatment event.Type: GrantFiled: May 3, 2016Date of Patent: November 7, 2017Assignee: ZOLL Medical CorporationInventor: John Amann
-
Patent number: 9808637Abstract: An implantable medical device system includes a pacemaker and an extravascular implantable cardioverter defibrillator (ICD). The pacemaker is configured to acquire a cardiac electrical signal, determine RR intervals from the cardiac electrical signal, apply ventricular tachycardia detection criteria solely to the RR intervals, detect ventricular tachycardia (VT) when the detection criteria are met; and deliver anti-tachycardia pacing in response to detecting the VT before the extravascular ICD delivers a shock therapy.Type: GrantFiled: August 11, 2015Date of Patent: November 7, 2017Assignee: Medtronic, Inc.Inventors: Vinod Sharma, Robert W. Stadler
-
Patent number: 9808638Abstract: The device includes a cardiac therapy circuit with a first terminal, and a peripheral therapy circuit with a second terminal. These terminals can either receive a cardiac detection/stimulation lead or a peripheral detection/stimulation lead of an organ. The device is configured to recognize the leads and automatically configure the connection terminals according to the type of lead received by the terminal. This includes discrimination methods for identifying the terminal on which a cardiac signal is detected, and selectively activating the cardiac therapy circuit and the peripheral therapy circuit based on the detection of the cardiac signal on a lead.Type: GrantFiled: November 18, 2015Date of Patent: November 7, 2017Assignee: SORIN CRM SASInventors: Hervé Blumstein, Hervé Mével
-
Patent number: 9808639Abstract: A fail-safe visual indicator (62) for indicating the readiness status of a medical device is described. The visual indicator incorporates iconic status indications (67, 70) which are easier to understand for users of all nationalities and languages. The status indications are superimposed upon each other in order to reduce the space required on the medical device for the indicator.Type: GrantFiled: December 17, 2013Date of Patent: November 7, 2017Assignee: Koninklijke Philips N.V.Inventor: Norman Maurice Delisle
-
Patent number: 9808640Abstract: A method and medical device for detecting a cardiac event that includes sensing cardiac signals from a plurality of electrodes forming a first sensing vector sensing a first interval of the cardiac signal during a predetermined time period and a second sensing vector simultaneously sensing a second interval of the cardiac signal during the predetermined time period, identifying each of the first interval and the second interval as being one of shockable and not shockable in response to first processing of the first interval and the second interval and in response to second processing of one or both of the first interval and the second interval, the second processing being different from the first processing, and determining whether to deliver therapy for the cardiac event in response to identifying each of the first interval and the second interval as being one of shockable and not shockable in response to both the first processing and the second processing of the first interval and the second interval.Type: GrantFiled: April 10, 2014Date of Patent: November 7, 2017Assignee: Medtronic, Inc.Inventor: Xusheng Zhang
-
Patent number: 9808641Abstract: The invention relates to a system for electrical and/or magnetic neuronal stimulation, comprising a signal generator for generating a stimulation signal, in particular an alternating-current stimulation signal, an applicator for applying the stimulation signal, in particular in an area on or directly around the optic nerve, a lead for deriving a measurement signal, in particular an EEG signal, a biomarker calculation unit for calculating a biomarker based on the measurement signal, and an optimization unit, in particular for performing a stochastic optimization process, for optimizing the value of the biomarker by varying the stimulation signal.Type: GrantFiled: September 5, 2014Date of Patent: November 7, 2017Assignee: EBS TECHNOLOGIES GMBHInventors: Ingo Wundrich, Udo Warschewske
-
Patent number: 9808642Abstract: A transcranial magnetic stimulation coil which is location-specific for frontal lobe regions, occipital lobe regions, parietal lobe regions, right temporal regions and left temporal regions is designed with multiple spaced apart stimulating elements having current flow in a substantially circular direction, and multiple return elements having current flow in substantially the same circular direction.Type: GrantFiled: February 1, 2016Date of Patent: November 7, 2017Assignee: BRAINSWAY, LTD.Inventors: Abraham Zangen, Yiftach Roth
-
Patent number: 9808644Abstract: A personal therapy compartment includes a base of size to receive a human patient. The compartment includes a bed in the base said bed being made of a light transmissive material. An array of lights mounted is below the bed to transmit light onto a body supported on the bed. A control panel controls at least the wavelength, intensity and pulsation of the light.Type: GrantFiled: March 3, 2009Date of Patent: November 7, 2017Assignee: Visibelle Derma Institute, Inc.Inventor: Steven J. Daffer
-
Patent number: 9808645Abstract: A method for treating at least one of Grade III capsular contracture and Grade IV capsular contracture in a mammalian subject includes positioning a laser device proximate to the subject. The method also includes applying low level near infrared radiation to an area of the subject proximate to tissue in the subject experiencing at least one of Grade III capsular contracture and Grade IV capsular contracture for treating the capsular contracture.Type: GrantFiled: January 16, 2015Date of Patent: November 7, 2017Assignee: Riancorp Pty LtdInventors: Patricia Ann Angel, William L. Scarlett
-
Patent number: 9808646Abstract: There is provided an applicator cartridge for delivery of a photoactivatable composition to a treatment site, having an applicator head and a reservoir adapted to receive the composition, which may be used with a photodynamic therapy device comprising an illuminating member. Methods of using the applicator cartridge and the device are also provided.Type: GrantFiled: October 27, 2010Date of Patent: November 7, 2017Assignee: KLOX TECHNOLOGIES INC.Inventors: Remigio Piergallini, Nikolaos Loupis, Lise Hébert
-
Patent number: 9808647Abstract: Methods and apparatus for the inactivation of infectious agents in, on or around a catheter residing in a patient's body cavity. The method comprises transmitting non-ultraviolet sterilizing electromagnetic radiation (EMR) substantially axially along an optical element in the catheter body. Through delivery of the sterilizing EMR to particular areas of highest infection, the present disclosure is able to inactivate the major sources of infection in catheters.Type: GrantFiled: March 13, 2013Date of Patent: November 7, 2017Assignee: Veritas Medical, L.L.C.Inventors: Nathaniel L. R. Rhodes, Adam E. Bracken, Martin de la Presa, Ahrash E. Poursaid, Ryan R. Coil, Mitchell Barneck, James Preston Allen
-
Patent number: 9808648Abstract: A system for immobilization of a patient body part for radiotherapy applications includes a device having at least one flanged support member which is mounted to a fixation surface. The device can receive and retain at least two sheets. A first sheet covers the anatomical contours of a first area of a body part. A second sheet covers the anatomical contours of a second area of the body part which is not covered by the first sheet. The system supports the immobilized body part free from the fixation surface by the two sheets and the device.Type: GrantFiled: May 8, 2013Date of Patent: November 7, 2017Assignee: DYNAMIC SYSTEMS HOLDING BVInventor: Leendert Gerrit De Mooij
-
Patent number: 9808649Abstract: The problem of securing the position of an internally placed medical device that extends out of the body during targeted high-dose-rate (HDR) brachytherapy is solved by a uniquely configured immobilization system that can be utilized to stabilize medical devices placed, for example, within the uterus or cervix. During the process of transporting a patient from the location where the HDR applicator is emplaced, for example, where the tandem and ring is placed within the cervix of a patient, to the location where the treatment is actually applied to the tissue, the medical device can move out of place and in so doing cause discomfort, pain, or an ineffective treatment for the patient. The embodiments of this immobilization system can include a strap apparatus, a straddling girdle, and bracket that can be attached to a patient. This immobilization system ensures the position of an internally placed medical device during targeted HDR brachytherapy.Type: GrantFiled: January 6, 2017Date of Patent: November 7, 2017Assignee: MEDICAL TOOL & TECHNOLOGY, LLCInventors: Richard David Helmig, John Scott Wheeler
-
Patent number: 9808650Abstract: A method for brachytherapy in a lumpectomy cavity of a breast including, positioning a distal end of a brachytherapy device within the cavity, expanding an expandable surface portion located between proximal and distal ends of the device within the cavity, the source lumen tubes defining a curved configuration within the cavity; and positioning a source of radiation sequentially within one or more source lumens of the source lumen tubes according to a brachytherapy treatment plan. The device includes an inner tube, and a plurality of source lumen tubes located around the inner tube and including distal ends secured together with the inner tube at the distal end disposed within the body cavity, the source lumen tubes comprising proximal portions sufficiently long to extend outside the breast.Type: GrantFiled: July 8, 2015Date of Patent: November 7, 2017Assignee: Theragenics CorporationInventors: Jack C. White, David Wesley Stephens, Amit Prakash Govil, Joshua J. Bergman, Nathan Christopher Griffith, Kyle Kevin Millage
-
Patent number: 9808651Abstract: Medical systems, devices, and methods provide improved radiosurgical techniques for treatment of anxiety disorders (such as Post-Traumatic Stress Disorder (PTSD), Generalized Anxiety Disorder (GAD), Panic Disorder, Social Phobia, Specific Phobia, and the like). Radiation can be directed from a radiation source outside the patient toward a target tissue deep within the patient's brain using a stereotactic radiosurgical platform, typically without having to impose the surgical trauma associated with accessing deep brain tissues. The target will often include at least a portion of the amygdala, with exemplary treatments being directed to targets that are limited to a sub-region of the amygdala. Rather than applying sufficient radiation to kill the neural tissue within the target, a cellularly sub-lethal dose of the radiation may be applied.Type: GrantFiled: May 22, 2013Date of Patent: November 7, 2017Inventors: M. Bret Schneider, John R. Adler, Jr.
-
Patent number: 9808652Abstract: A collimator for a radiotherapy apparatus comprising a block of radiation-attenuating material having a front face forming the leading edge of the block and at least one main rear face defining the trailing edge of the block, in which the least one main rear face has a material disposed thereon and is non-parallel to the front face. The collimator may form part of a radiotherapy apparatus, and methods of operation of such apparatus are described.Type: GrantFiled: December 29, 2016Date of Patent: November 7, 2017Assignee: Elekta AB (Publ)Inventors: Virgil Willcut, Martin Broad, David Anthony Roberts
-
Patent number: 9808653Abstract: Methods for treating a human patient having a subarachnoid hematoma, such as to prevent cerebral vasospasm or to reduce the severity of cerebral vasospasm in the patient, and associated devices, systems, and methods are disclosed herein. In a particular embodiment, a thrombolytic agent is introduced extravascularly into a subarachnoid region including the hematoma. A headset configured for hands-free delivery of transcranial ultrasound energy is connected to the patient and used to deliver ultrasound energy to the subarachnoid region to enhance the thrombolytic effect of the thrombolytic agent. The type and/or dosage of the thrombolytic agent can be selected based on the enhanced thrombolytic effect. For example, the enhanced thrombolytic effect can allow the therapeutically effective use of less aggressive thrombolytic agents and/or lower dosages of thrombolytic agents. In some cases, this can reduce the clinical probability of additional cerebral hemorrhage.Type: GrantFiled: May 24, 2013Date of Patent: November 7, 2017Inventor: David W. Newell
-
Patent number: 9808654Abstract: Compositions and methods are provided for a post-procedure care following the treatment of skin with cosmetic skin resurfacing treatments, which include without limitation a variety of laser treatments, chemical peeling and dermabrasion, by applying a silicone-based gel formulation in combination with therapeutic peptides. Peptides of interest include one or more of transforming growth factor, epidermal growth factor, and basic fibroblast growth factor. The formulation may further comprise an effective dose of one or more acylated peptides, which peptides are active in remodeling of the skin.Type: GrantFiled: February 11, 2013Date of Patent: November 7, 2017Assignee: JAN MARINI SKIN RESEARCHInventors: Jan Marini, Subhash J. Saxena
-
Patent number: 9808655Abstract: A method for determining a characteristic such as partial pressure or percentage of a gaseous constituent in a first gas mixture flow in a flow chamber in which there is alternating flow in opposite directions between the first gas mixture flow and a second gas mixture flow. The steps may include a) introducing the first gas mixture flow into a sensing chamber when the first gas mixture flow flows in the flow chamber, b) preventing introduction of gas from the flow chamber into the sensing chamber at least when the second gas mixture flow flows in the flow chamber, c) sensing the characteristic of the first gas mixture flow in the sensing chamber.Type: GrantFiled: February 28, 2011Date of Patent: November 7, 2017Assignee: Zodiac AerotechnicsInventor: Matthieu Fromage
-
Patent number: 9808656Abstract: A powered air purifying respirator (PAPR). The PAPR comprises an electric motor mechanically coupled to a blower, an oxygen sensor, an alarm device, and a controller coupled to the oxygen sensor and to the electric motor, wherein the controller controls the electric motor, wherein the controller determines if the oxygen concentration is deficient, and wherein the controller commands the alarm device to present an indication when the oxygen concentration is deficient.Type: GrantFiled: January 9, 2012Date of Patent: November 7, 2017Assignee: Honeywell International Inc.Inventors: Vinay Kumar Vinnakota, Praveen Kumar Palacharla, Swapnil Gopal Patil
-
Patent number: 9808657Abstract: A directional valve includes a fixing lug (13), which is arranged eccentrically to a valve membrane (16) and is arranged at a valve housing (15). The dimensions of the fixing lug (13) are selected for fixing the valve membrane (16) relative to the sealing surface (2) of valve seat (1). The size of the eccentric offset (x) is in a range between 8% and 15% of the axis length (D) of the greatest longitudinal extension of valve membrane (16).Type: GrantFiled: May 9, 2012Date of Patent: November 7, 2017Assignee: Dräger Safety AG & Co. KGaAInventors: Michael Rosert, Dennis Leske, Harald Heyer, Thomas Pancur
-
Patent number: 9808658Abstract: An installation for supporting a worker on a tank: The tank includes a plurality of vertical staves held to define a peripheral wall by a plurality of hoops. A top bracket at the top hoop has a tie-on receiving fixture for attachment to a worker's tie-on at the outer end of the bracket. The tie-on bracket on the top hoop is shaped to not pivot up and down around the top hoop. At least one lower hoop is located on the side of the tank. Each lower bracket at each lower hoop has a tie-on receiving fixture for attachment to a worker's tie-on at the outer end of the bracket. Each lower bracket is shaped and positioned for being able to be pivoted up and down around its lower hoop. A threaded end region on the end of a hoop segment passes through a hole in the respective bracket. A nut is tightened on the threaded end region for holding the bracket to a junction fixture on the end of a respective hoop segment.Type: GrantFiled: August 10, 2016Date of Patent: November 7, 2017Assignee: ROSENWACH TANK CO., LLCInventor: Andrew Rosenwach
-
Patent number: 9808659Abstract: A roping harness having a sit harness, pair of shoulder straps, and at least one securing link having a first strap unfurlable in the lengthwise direction, and composed of two superposed strands secured to one another by a stitching area, designed to tear when a fall happens separating the strands and moving the connecting loop from a lowered to a raised position. The securing link includes a second strap connecting the sternal attachment to the corresponding sit harness strap. The first strap bottom strand is attached to the belt and is shorter length than the unfurlable top strand. The top strand is fixed to the sternal attachment, such that tearing of the stitching area releases the bottom strand. The top strand moves to the raised position attached to the sternal attachment to transfer the reaction of the shock of a fall onto the second strap connected with the leg loops.Type: GrantFiled: May 3, 2016Date of Patent: November 7, 2017Assignee: ZEDELInventor: Nicolas Chevalier
-
Patent number: 9808660Abstract: Apparatus and method for firefighting includes a containerless core of a fire retardant material, compressed to form a prolate spheroid shape. A shaft with fins and a carrying hook can extend from the core tail. The core can have a core charge of an explosive material within the core channel. An altimeter sensor coupled to the core charge and a triggering mechanism is coupled between the altimeter sensor and the core charge, and causes the triggering mechanism to detonate the core charge when the apparatus reaches an altitude. A delivery apparatus is included with a frame having carry harness, and at least one holding hook on the frame coupled to the carrying hook. The carry harness supports delivery apparatus in transport. Powders of calcium carbonate, magnesium carbonate, ammonium sulfate, diammonium sulfate, diammonium phosphate, ammonium polyphosphate, or monoammonium phosphate can be intermixed as fire retardant, along with indigenous plant seed.Type: GrantFiled: March 31, 2015Date of Patent: November 7, 2017Inventor: Robert Shane Kilburn
-
Patent number: 9808661Abstract: Extinguishing a fire by pressurizing a tank containing an extinguishing liquid. According to the invention, the tank containing the liquid is provided with an expulsion outlet at a front end, a gas generator (17) is installed at a rear end, and a diaphragm forming an inflatable bag (19) is installed inside the tank, being folded prior to triggering in a confinement space at the front of the gas generator, the outlet from the generator being associated with a deflector (47) including a rearwardly-directed ejection passage (49).Type: GrantFiled: March 6, 2012Date of Patent: November 7, 2017Assignee: PYROALLIANCEInventors: Eric Gibaud, Pierre Humbert, Bertrand Haguenauer, Alexis Huet
-
Patent number: 9808662Abstract: A method for consistently placing a crossbar on a pin on a standard used in a vertical distance field event such as high jump and pole vault. The crossbar has a crossbar end with a directional index on at least one surface. In another example embodiment, the crossbar end has a plurality of ordinal indicia alone or with the directional index. A worker notes the placement of the directional index and the ordinal indicia when placing the crossbar a first time. The worker subsequently places the crossbar making sure the directional index and ordinal indicia appear in the same position relative to the standards and relative to the pin on the standard.Type: GrantFiled: November 20, 2015Date of Patent: November 7, 2017Inventor: David M. File